Search
Subscribe Now
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 4 of 100
Politics
Trump eyes new tariffs on semiconductors and pharmaceuticals as U.S. only makes 20% of world’s drugs and 0% of advanced logic chips
By
Elaine Kurtenbach
and
The Associated Press
April 15, 2025
Health
Europe’s pharma titans confront von der Leyen with threat to yank $113 billion from EU and relocate to U.S. as Trump plans ‘major’ tariffs
By
Ryan Hogg
April 9, 2025
Finance
Could Trump tariffs solve Ireland’s housing crisis?
By
Ryan Hogg
April 8, 2025
Newsletters
How Trump’s import tariffs shocked tech stocks
By
Andrew Nusca
April 4, 2025
Retail
Siemens to boost drug discoveries using AI through the $5.1 billion acquisition of U.S. software firm Dotmatics
By
AFP
April 3, 2025
Features
Will AI ever cure cancer? The multibillion-dollar race to bring the first AI-discovered drug to market
By
Erika Fry
April 3, 2025
Leadership
GSK employees perform anonymous ‘180’ surveys on their bosses, and CEO Emma Walmsley isn’t exempt
By
Ryan Hogg
April 2, 2025
Health
Mark Cuban warns Trump’s tariffs mean his Cost Plus Drugs ‘won’t have a choice’ but to raise prices for consumers
By
Ani Freedman
April 1, 2025
Tech
As a kid, she raised money to cure cystic fibrosis. Now she’s the CEO of a $2.6 billion genetic testing company
By
Andrew Nusca
March 31, 2025
Finance
Vietnam seizes 1.4 tons of ketamine as police bust country’s biggest synthetic drug factory
By
AFP
March 27, 2025
Tech
Sanofi’s chief digital officer says remote work means employees lose the ‘serendipity’ needed to innovate
By
Ryan Hogg
March 27, 2025
Tech
‘I’m not trying to turn GSK into Google’: How GSK’s Silicon Valley veteran has transformed the pharma giant into a tech powerhouse
By
Ryan Hogg
March 25, 2025
Tech
AstraZeneca to buy cell therapy biotech for up to $1 billion
By
Ashleigh Furlong
and
Bloomberg
March 17, 2025
Commentary
My son’s rare disease diagnosis spurred me to ditch Big Pharma for a biotech startup
By
Michelle Werner
March 10, 2025
Commentary
The crisis over GLP-1 out-of-pocket costs deepens—it’s time for health-care leaders to step up
By
Wendy Barnes
March 4, 2025
Most Popular
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’
By
Emma Burleigh
Cybersecurity
Top AI leaders are begging people not to use Moltbook, a social media platform for AI agents: It’s a ‘disaster waiting...
By
Eva Roytburg
Politics
Meet the Palm Beach billionaire who paid $2 million for a private White House visit with Trump
By
Tristan Bove